Roche
ROG.SW
₹27,316
Share price
-1.05%
Change (1 day)
13.12%
Change (1 year)
Categories
Revenue for Roche (ROG.SW)
Revenue in 2024: ₹5.937 Trillion
According to Roche's latest financial reports the company's current revenue (TTM 
) is ₹5.937 Trillion. In 2024 the company made a revenue of ₹5.937 Trillion a decrease over the revenue in the year 2023 that were of ₹6.178 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Roche from 1998 to 2024
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2024 | ₹5.937 T | -3.91% |
| 2023 | ₹6.178 T | 0.91% |
| 2022 | ₹6.123 T | 3.65% |
| 2021 | ₹5.907 T | 3.89% |
| 2020 | ₹5.686 T | 4.26% |
| 2019 | ₹5.454 T | 9.8% |
| 2018 | ₹4.967 T | 5.58% |
| 2017 | ₹4.704 T | 10.25% |
| 2016 | ₹4.267 T | 1.88% |
| 2015 | ₹4.188 T | 1.49% |
| 2014 | ₹4.126 T | -8.94% |
| 2013 | ₹4.531 T | 5.76% |
| 2012 | ₹4.285 T | 9.97% |
| 2011 | ₹3.896 T | -10.75% |
| 2010 | ₹4.366 T | 7.11% |
| 2009 | ₹4.076 T | 8.43% |
| 2008 | ₹3.759 T | 7.33% |
| 2007 | ₹3.502 T | 17.93% |
| 2006 | ₹2.970 T | 28.04% |
| 2005 | ₹2.319 T | 4.26% |
| 2004 | ₹2.224 T | 2.53% |
| 2003 | ₹2.169 T | -31.74% |
| 2002 | ₹3.178 T | 0.99% |
| 2001 | ₹3.147 T | 1.71% |
| 2000 | ₹3.094 T | 4.01% |
| 1999 | ₹2.975 T | 11.78% |
| 1998 | ₹2.661 T |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | ₹7.677 T | 29.32% | 🇺🇸 USA |
 Merck MRK | ₹5.494 T | -7.47% | 🇺🇸 USA |
 Pfizer PFE | ₹5.368 T | -9.58% | 🇺🇸 USA |
 Sanofi SNY | ₹4.073 T | -31.39% | 🇫🇷 France |
 Novartis NVS | ₹4.574 T | -22.95% | 🇨🇭 Switzerland |
 GlaxoSmithKline GSK | ₹3.488 T | -41.25% | 🇬🇧 UK |
 Abbott Laboratories ABT | ₹3.639 T | -38.70% | 🇺🇸 USA |
 Amgen AMGN | ₹2.933 T | -50.60% | 🇺🇸 USA |
 Becton Dickinson BDX | ₹1.793 T | -69.79% | 🇺🇸 USA |